Key result
Cerebral microdialysis during deep brain stimulation for Parkinson's disease requires optimization of technical features to overcome pitfalls like improper probe design and ineffective perfusion rates.
This review highlights the technical requirements and pitfalls of using cerebral microdialysis during deep brain stimulation for Parkinson's disease.
Technical optimization of microdialysis in DBS is required to avoid pitfalls; leaves open standardized protocols for Parkinson's research.
Cerebral microdialysis is a chemical detection method capable of identifying and simultaneously sampling a wide range of substances in the micromilieu of the monitoring probe. The interstitial space of biological tissues and fluids is sampled through a thin fenestrated dialysis catheter inserted into the brain. The technique has been reported in patients with Parkinson's disease. However, the procedure is not widely used by neurosurgeons, possibly owing to unclear indications and poor effective benefits, mostly secondary to significant pitfalls. In spite of the feasibility of microdialysis in humans, many factors can affect the quality of the process. Possible pitfalls include improperly designed probe, probe insertion effects, ineffective perfusion rate, issues to optimize stabilization period, and insufficient volume sample. This article reviews those key technical features necessary for performing microdialysis in humans during deep brain stimulation for Parkinson's Disease.
No takes yet. Share an insight, caveat, or question.
Raquel Chacon Ruiz Martinez (2016) conducted a review in Parkinson's Disease. Cerebral microdialysis was evaluated. Cerebral microdialysis during deep brain stimulation for Parkinson's disease requires optimization of technical features to overcome pitfalls like improper probe design and ineffective perfusion rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: